LAUSANNE, Switzerland SOPHiA GENETICS, the global leader in Data-Driven Medicine that has created SOPHiA Artificial Intelligence, today announced the close of a $30 million Series D funding round. The round was led by London-based Balderton Capital joined by 360º Capital Partners alongside existing investors British tech star Mike Lynch's Invoke Capital and Alychlo, the investment firm of Belgian pharmaceutical entrepreneur Marc Coucke. [...]

vermicon AG and Sysmex Europe GmbH agree on partnership for product distribution  MUNICH   Sysmex Europe GmbH, a subsidiary of the international enterprise Sysmex Corporation, andvermicon AG, hereby announce the start of a business partnership. The first result of this alliance, a combination of flow cytometry and gene probe technology known as the 'Flow VIT® Solution' detection system, will provide highly sensitive and sector-specific solutions for industrial microbiology with the aim of raising quality control to a new level.  For almost 50 years, Sysmex Partec GmbH, a subsidiary of the Sysmex [...]

- Sizes range from 50-liter to 2,000-liter manufacturing scale - Industry-leading design offers flexibility, scalability and ease-of-use BILLERICA, Mass. -- MilliporeSigma today announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma's Mobius® single-use bioreactors. Celonic, which produces biosimilars and also offers a cell line development platform, [...]

MEDFORD, Mass. -- GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with the majority of GreenLight's existing investors, including Kodiak Venture Partners, MLSCF, Syngenta Ventures and others.  GreenLight is harnessing its [...]

Qlucore, a leader in the development of bioinformatics visualization software, has today launched the latest version of its advanced data analysis software. Qlucore Omics Explorer 3.3 includes a new Next Generation Sequencing (NGS) Module and additional new functionalities. Qlucore Omics Explorer is a next-generation bioinformatics software program for broad usage, known for its easy to [...]

FOSS announces BacSomatic, the first ever integrated bacteria and somatic cell counter for testing the hygienic quality of milk. The small, automated instrument offers a fast alternative to manual assay or semi-automated methods requiring reagent handling. It delivers accurate results for bacteria count and somatic cell within nine minutes or two and half minutes for somatic cell [...]

SAN DIEGO – Edico Genome today announced the commercial deployment of its DRAGENTM Bio-IT Platform on Amazon Web Services (AWS) Marketplace, enabled by the recent general availability of the Amazon Elastic Compute Cloud (Amazon EC2) F1 instance type. Amazon EC2 F1 instances are powered by Xilinx Virtex UltraScale+ field programmable gate arrays (FPGAs) and are designed to provide capabilities for [...]

Advanced Analytical Technologies, Inc (AATI) is excited to partner with Illumina to support collaborations and co-marketing activities involving our Fragment Analyzer™ Automated CE Systems for quality assessment of nucleic acids in Illumina next-generation sequencing (NGS) workflows. Assessing nucleic acid quality is essential for the success of NGS applications. The Fragment Analyzer provides a scalable method, tested by Illumina, for [...]

BC|RQUEST provides researchers direct access to genomic and phenotypic data from the United States and Europe BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data. BC|RQUEST facilitates browsing and analytics of genomic and clinical data that [...]

Beacon™ OptoFluidic Platform to Automate Workflows for Greater Efficiencies Emeryville, CA – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, today announced a strategic project with Bayer AG, Germany (Bayer), focused on the innovation and acceleration of cell line development, antibody discovery, and research. As part of the [...]